News · 26 weeks76-38%
2026-03-012026-08-23
Mix3290d
- Insider20(63%)
- SEC Filings8(25%)
- Other2(6%)
- Earnings2(6%)
Latest news
25 items- SECClover Health Investments Corp. filed SEC Form 8-K: Regulation FD Disclosure, Financial Statements and Exhibits8-K - CLOVER HEALTH INVESTMENTS, CORP. /DE (0001801170) (Filer)
- INSIDERInterim CFO Thornton Joseph Clay sold $78,032 worth of shares (17,775 units at $4.39), decreasing direct ownership by 1% to 1,249,526 units (SEC Form 4) (tax liability)4 - CLOVER HEALTH INVESTMENTS, CORP. /DE (0001801170) (Issuer)
- INSIDERChief Legal Officer Soares Karen was granted 108,695 shares, increasing direct ownership by 7% to 1,614,217 units (SEC Form 4)4 - CLOVER HEALTH INVESTMENTS, CORP. /DE (0001801170) (Issuer)
- INSIDERInterim CFO Thornton Joseph Clay was granted 54,347 shares, increasing direct ownership by 4% to 1,267,301 units (SEC Form 4)4 - CLOVER HEALTH INVESTMENTS, CORP. /DE (0001801170) (Issuer)
- INSIDERChief Executive Officer Toy Andrew sold $408,261 worth of shares (87,798 units at $4.65), decreasing direct ownership by 0.92% to 9,459,316 units (SEC Form 4) to satisfy withholding tax4 - CLOVER HEALTH INVESTMENTS, CORP. /DE (0001801170) (Issuer)
- SECSEC Form 10-Q filed by Clover Health Investments Corp.10-Q - CLOVER HEALTH INVESTMENTS, CORP. /DE (0001801170) (Filer)
- SECClover Health Investments Corp. filed SEC Form 8-K: Results of Operations and Financial Condition, Financial Statements and Exhibits8-K - CLOVER HEALTH INVESTMENTS, CORP. /DE (0001801170) (Filer)
- PRClover Health Reports Second Quarter 2026 ResultsBusiness Highlights: Delivered strong second quarter 2026 GAAP Net Income alongside continued market-leading Medicare Advantage membership growthImproved Full Year 2026 guidance across all metricsIncreasing confidence for 2027 outlook, supported by strong cohort development, continued clinical engagement, and the added flexibility of a 4.5 Star payment year Financial Results: Second quarter 2026 GAAP Net Income of $28 million, an improvement of $39 million year-over-yearSecond quarter 2026 Medicare Advantage membership of 157,309, up 48% year-over-year, and Total revenues of $743 million, up 56% year-over-yearSecond quarter 2026 Consolidated Gross Profit of $153 million, up 54% year
- PRClover Health to Participate in Upcoming Canaccord Genuity 46th Annual Growth ConferenceWILMINGTON, Del., July 22, 2026 (GLOBE NEWSWIRE) -- Clover Health Investments, Corp. (NASDAQ:CLOV) ("Clover," "Clover Health" or the "Company"), today announced that its Interim Chief Financial Officer, Clay Thornton, will present at the 2026 Canaccord Genuity 46th Annual Growth Conference on Tuesday, August 11, 2026, at 8:30 a.m. Eastern Time. A live webcast and replay of the presentation and Q&A session will be accessible on Clover Health's investor relations website at https://investors.cloverhealth.com/. About Clover Health:Clover Health (NASDAQ:CLOV) is a physician enablement technology company committed to bringing access to great healthcare to everyone on Medicare. This includes a
- INSIDERChief Legal Officer Soares Karen sold $233,167 worth of shares (51,700 units at $4.51) as part of a pre-agreed trading plan, decreasing direct ownership by 3% to 1,505,522 units (SEC Form 4)4 - CLOVER HEALTH INVESTMENTS, CORP. /DE (0001801170) (Issuer)
- INSIDERCEO, Medicare Advantage Reynoso Jamie L. sold $21,921 worth of shares (4,839 units at $4.53) as part of a pre-agreed trading plan, decreasing direct ownership by 0.17% to 2,814,640 units (SEC Form 4)4 - CLOVER HEALTH INVESTMENTS, CORP. /DE (0001801170) (Issuer)
- SECClover Health Investments Corp. filed SEC Form 8-K: Other Events8-K - CLOVER HEALTH INVESTMENTS, CORP. /DE (0001801170) (Filer)
- INSIDERChief Executive Officer Toy Andrew sold $292,860 worth of shares (62,711 units at $4.67), decreasing direct ownership by 0.65% to 9,547,114 units (SEC Form 4) (tax withholding)4 - CLOVER HEALTH INVESTMENTS, CORP. /DE (0001801170) (Issuer)
- INSIDERCEO, Counterpart Health Wai Conrad sold $113,084 worth of shares (24,215 units at $4.67), decreasing direct ownership by 2% to 1,145,699 units (SEC Form 4) to satisfy withholding tax4 - CLOVER HEALTH INVESTMENTS, CORP. /DE (0001801170) (Issuer)
- INSIDERCEO, Medicare Advantage Reynoso Jamie L. sold $61,266 worth of shares (13,119 units at $4.67), decreasing direct ownership by 0.46% to 2,819,479 units (SEC Form 4) (tax withholding)4 - CLOVER HEALTH INVESTMENTS, CORP. /DE (0001801170) (Issuer)
- INSIDERChief Legal Officer Soares Karen sold $49,124 worth of shares (10,519 units at $4.67), decreasing direct ownership by 0.67% to 1,557,222 units (SEC Form 4) to cover taxes4 - CLOVER HEALTH INVESTMENTS, CORP. /DE (0001801170) (Issuer)
- INSIDERInterim CFO Thornton Joseph Clay sold $21,622 worth of shares (4,630 units at $4.67), decreasing direct ownership by 0.38% to 1,212,954 units (SEC Form 4) (for withholding tax)4 - CLOVER HEALTH INVESTMENTS, CORP. /DE (0001801170) (Issuer)
- INSIDERCEO, Medicare Advantage Reynoso Jamie L. sold $11,157 worth of shares (2,384 units at $4.68) as part of a pre-agreed trading plan, decreasing direct ownership by 0.08% to 2,832,598 units (SEC Form 4)4 - CLOVER HEALTH INVESTMENTS, CORP. /DE (0001801170) (Issuer)
- PRClover Health to Report Second Quarter 2026 Financial Results on August 5, 2026WILMINGTON, Del., July 09, 2026 (GLOBE NEWSWIRE) -- Clover Health Investments, Corp. (NASDAQ:CLOV) ("Clover," "Clover Health" or the "Company"), today announced that it will release its financial results after the market closes on Wednesday, August 5, 2026. The Company’s management will host a webcast presentation at 5:00 p.m. Eastern Time on the same day to discuss the company’s business and financial performance for the quarter. Second Quarter 2026 Conference Webcast Details: What: Clover Health’s Second Quarter 2026 Earnings Conference CallWhen: Wednesday, August 5, 2026, at 5:00 p.m. Eastern TimeWebcast: To access the webcast, you may register at https://clover-health-2q-2026-earning
- PRClinical Excellence in Continuity of Care: Counterpart Assistant (CA) Use Associated With Stronger Performance Across Transitions of Care Measures and Post-Hospitalization Follow-UpSAN FRANCISCO, July 07, 2026 (GLOBE NEWSWIRE) -- Counterpart Health, Inc. ("Counterpart"), a wholly owned subsidiary of Clover Health Investments, Corp. (Nasdaq: CLOV) ("Clover" or "Clover Health"), and a leading AI-powered physician enablement platform, today released findings within the whitepaper "Clinical Excellence in Continuity of Care: A Real-World Analysis of Counterpart Assistant's Role in Post-Hospitalization Follow-up." The whitepaper examines the relationship between CA use by primary care physicians ("PCPs") and performance on high-risk care transition outcomes, including two HEDIS®1 quality measures within Clover Health’s Medicare Advantage population: Transitions of Care ("
- INSIDERCEO, Medicare Advantage Reynoso Jamie L. sold $32,765 worth of shares (6,229 units at $5.26), decreasing direct ownership by 0.22% to 2,834,982 units (SEC Form 4) (tax liability)4 - CLOVER HEALTH INVESTMENTS, CORP. /DE (0001801170) (Issuer)
- INSIDERChief Executive Officer Toy Andrew sold $1,667,692 worth of shares (313,476 units at $5.32), decreasing direct ownership by 3% to 9,609,825 units (SEC Form 4) (withholding obligation)4 - CLOVER HEALTH INVESTMENTS, CORP. /DE (0001801170) (Issuer)
- SECClover Health Investments Corp. filed SEC Form 8-K: Other Events8-K - CLOVER HEALTH INVESTMENTS, CORP. /DE (0001801170) (Filer)
- INSIDERCEO, Medicare Advantage Reynoso Jamie L. sold $11,281 worth of shares (2,360 units at $4.78) as part of a pre-agreed trading plan, decreasing direct ownership by 0.08% to 2,841,211 units (SEC Form 4)4 - CLOVER HEALTH INVESTMENTS, CORP. /DE (0001801170) (Issuer)
- INSIDERVP OF FINANCE AND CONTROLLER Oldakowski Joseph Frank sold $58,816 worth of shares (12,102 units at $4.86), decreasing direct ownership by 4% to 299,067 units (SEC Form 4) (for tax liability)4 - CLOVER HEALTH INVESTMENTS, CORP. /DE (0001801170) (Issuer)
CLOV FAQ
6 questionsWhat does Clover Health Investments Corp. do?
Clover Health Investments, Corp. operates as a Medicare Advantage insurer in the United States. The company through its software platform provides preferred provider organization and health maintenance organization health plans for Medicare-eligible consumers. Clover Health Investments, Corp. was founded in 2014 and is headquartered in Franklin, Tennessee.Where does CLOV stock trade?
Clover Health Investments Corp. (CLOV) is listed on NASDAQ.What sector and industry is CLOV in?
Clover Health Investments Corp. operates in the Health Care sector, Medical Specialities industry.What are analysts saying about CLOV?
Clover Health Investments Corp. has had 8 recent analyst actions on file. The most recent action was from Craig Hallum: Buy with a $600.00 price target on 2024-12-17. Recent price targets range from $250.00 to $600.00.What companies are similar to CLOV?
Notable peers in the same industry include UNH (UnitedHealth Group Incorporated), ANTM (Anthem Inc.), ELV (Elevance Health Inc.), CI (The Cigna Group), NTRA (Natera Inc.). Compare CLOV side-by-side with any of them on Quantisnow.How can I track CLOV on Quantisnow?
Quantisnow aggregates Clover Health Investments Corp.'s SEC filings, analyst ratings, insider transactions, FDA approvals, and press releases the moment they hit the wire (Wall Street's wire, on your screen.). Follow CLOV to receive live email and push alerts on every new disclosure.